Wow.
I want to confirm here; you are saying that no matter what you put in your initial work request, in your experience, Balfour Beatty was able...
We need to take a look at that process and see if there are changes that need to be made.
But my question is, what are you doing to make sure that we don't come to a place like this again, and to hold McKinsey accountable for fail...
I led a bipartisan letter to the FDA, raising concerns about the apparent conflicts of interests surrounding the consulting firm McKinsey.
I think it is not sufficient for us to rely on self-reporting anymore.
Well, I am going to hold off on that because I have a few other questions and limited time.
So I am going to follow-up with you additionally, because I am still interested in wanting an answer to whether you are going to suspend con...
For some medications with serious safety concerns, FDA requires manufacturers to set up risk evaluation and mitigation strategies, otherwise...
And it is using the notion of patient safety to delay the development of additional drugs that could bring down the cost.
REMS has really had two problems with, the first one was we as the generics, as we reverse engineer, need the product that we are reverse en...
I wonder if you have consulted with Secretary Yellen on this proposal?
It is imperative for this Committee to understand what you will need from Congress to be successful.
I appreciate your leadership.
I do not know if everybody can see this. It is kind of low, but we will hold--yeah. This is a--picture is worth a thousand words.
They have a goal of $500 billion in trade by 2025. That dwarfs what we are looking at in the United States and I think this is important to ...
I think that speaks to this committee's work and the need to move on those nominations as soon as we can get them.
The Securing a Strong Retirement Act and RISE Act in the House, as well as the Improving Access to Retirement Savings Act--a Senate bill co-...
